Northern Trust Corp Wave Life Sciences Ltd. Transaction History

Northern Trust Corp

  • $600 Billion
  • Q3 2024

A detailed history of Northern Trust Corp transactions in Wave Life Sciences Ltd. stock. As of the latest transaction made, Northern Trust Corp holds 799,365 shares of WVE stock, worth $10.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
799,365
Previous 751,725 6.34%
Holding current value
$10.8 Million
Previous $3.75 Million 74.73%
% of portfolio
0.0%
Previous 0.0%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$5.12 - $9.01 $243,916 - $429,236
47,640 Added 6.34%
799,365 $6.55 Million
Q2 2024

Aug 14, 2024
SELL
$4.38 - $6.48 $24,379 - $36,067
-5,566 Reduced 0.73%
751,725 $3.75 Million
Q1 2024

May 14, 2024
BUY
$3.54 - $6.84 $463,177 - $894,952
130,841 Added 20.89%
757,291 $4.67 Million
Q4 2023

Feb 13, 2024
BUY
$4.16 - $6.87 $464,006 - $766,279
111,540 Added 21.66%
626,450 $3.16 Million
Q3 2023

Nov 13, 2023
BUY
$3.56 - $5.75 $30,712 - $49,605
8,627 Added 1.7%
514,910 $2.96 Million
Q2 2023

Aug 11, 2023
BUY
$3.51 - $4.69 $1.34 Million - $1.79 Million
382,153 Added 307.87%
506,283 $1.84 Million
Q1 2023

May 15, 2023
BUY
$3.58 - $6.3 $18,347 - $32,287
5,125 Added 4.31%
124,130 $537,000
Q4 2022

Feb 13, 2023
BUY
$3.18 - $7.0 $36,277 - $79,856
11,408 Added 10.6%
119,005 $833,000
Q3 2022

Nov 14, 2022
BUY
$2.37 - $4.28 $56,026 - $101,179
23,640 Added 28.16%
107,597 $389,000
Q2 2022

Aug 12, 2022
SELL
$1.23 - $3.25 $378,334 - $999,664
-307,589 Reduced 78.56%
83,957 $273,000
Q1 2022

May 13, 2022
SELL
$2.0 - $3.28 $47,640 - $78,129
-23,820 Reduced 5.73%
391,546 $783,000
Q4 2021

Feb 08, 2022
BUY
$3.14 - $5.15 $128,290 - $210,413
40,857 Added 10.91%
415,366 $1.3 Million
Q3 2021

Nov 15, 2021
SELL
$4.89 - $7.12 $14,943 - $21,758
-3,056 Reduced 0.81%
374,509 $1.84 Million
Q2 2021

Aug 13, 2021
SELL
$5.65 - $7.47 $7,350 - $9,718
-1,301 Reduced 0.34%
377,565 $2.52 Million
Q1 2021

May 12, 2021
SELL
$5.61 - $12.01 $141,248 - $302,387
-25,178 Reduced 6.23%
378,866 $2.13 Million
Q4 2020

Feb 11, 2021
BUY
$6.99 - $9.26 $635,377 - $841,715
90,898 Added 29.03%
404,044 $3.18 Million
Q3 2020

Nov 16, 2020
BUY
$8.49 - $19.54 $233,126 - $536,548
27,459 Added 9.61%
313,146 $2.66 Million
Q2 2020

Aug 14, 2020
BUY
$7.44 - $11.29 $1,145 - $1,738
154 Added 0.05%
285,687 $2.97 Million
Q1 2020

May 14, 2020
SELL
$6.94 - $14.22 $28,454 - $58,302
-4,100 Reduced 1.42%
285,533 $2.68 Million
Q4 2019

Feb 14, 2020
SELL
$7.99 - $37.6 $2,604 - $12,257
-326 Reduced 0.11%
289,633 $2.32 Million
Q3 2019

Nov 13, 2019
BUY
$19.17 - $27.4 $472,885 - $675,903
24,668 Added 9.3%
289,959 $5.95 Million
Q2 2019

Aug 13, 2019
BUY
$22.93 - $42.84 $117,974 - $220,411
5,145 Added 1.98%
265,291 $6.92 Million
Q1 2019

May 13, 2019
BUY
$32.69 - $47.91 $1.09 Million - $1.59 Million
33,218 Added 14.64%
260,146 $10.1 Million
Q4 2018

Feb 12, 2019
SELL
$37.1 - $50.11 $27,787 - $37,532
-749 Reduced 0.33%
226,928 $9.54 Million
Q3 2018

Nov 14, 2018
BUY
$36.35 - $55.2 $222,898 - $338,486
6,132 Added 2.77%
227,677 $11.4 Million
Q2 2018

Sep 18, 2018
SELL
$33.85 - $50.65 $47,423 - $70,960
-1,401 Reduced 0.63%
221,545 $8.47 Million
Q2 2018

Aug 14, 2018
BUY
$33.85 - $50.65 $2.34 Million - $3.5 Million
69,175 Added 44.99%
222,946 $8.53 Million
Q1 2018

May 09, 2018
BUY
$32.45 - $54.7 $29,399 - $49,558
906 Added 0.59%
153,771 $6.17 Million
Q4 2017

Feb 14, 2018
SELL
$21.8 - $39.35 $96,944 - $174,989
-4,447 Reduced 2.83%
152,865 $5.37 Million
Q3 2017

Nov 13, 2017
BUY
$16.4 - $25.05 $2.58 Million - $3.94 Million
157,312
157,312 $3.42 Million

Others Institutions Holding WVE

# of Institutions
164
Shares Held
117M
Call Options Held
148K
Put Options Held
109K
View Full List

About Wave Life Sciences Ltd.

WVE Quotes by TradingView
  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $1.17B
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email